Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) — Strategic Asset Allocation Index
Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) has a Strategic Asset Allocation Index of 21.7% as of September 2022. Strategic assets (PP&E of CN¥224.54 Million plus long-term investments of CN¥-) total CN¥224.54 Million, measured against net assets of CN¥1.03 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
Shenzhen Bioeasy Biotechnology Co. Ltd. Strategic Asset Allocation Index (2017–2021)
This chart shows how Shenzhen Bioeasy Biotechnology Co. Ltd.'s Strategic Asset Allocation Index has evolved across 5 annual periods from 2017 to 2021. As of September 2022, the index stands at 21.7%, representing strategic assets of CN¥224.54 Million against net assets of CN¥1.03 Billion CNY. Explore 300942 cash generation efficiency to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. (2017–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Shenzhen Bioeasy Biotechnology Co. Ltd. from 2017 to 2021, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Shenzhen Bioeasy Biotechnology Co. Ltd. (300942) market capitalisation.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 15.2% | CN¥143.44 Million | CN¥143.44 Million | CN¥- | CN¥946.58 Million | ▲ +7.0 pp |
| 2020 | 8.2% | CN¥44.89 Million | CN¥44.89 Million | CN¥- | CN¥548.98 Million | ▲ +2.6 pp |
| 2019 | 5.6% | CN¥29.41 Million | CN¥29.41 Million | CN¥- | CN¥528.32 Million | ▼ -1.5 pp |
| 2018 | 7.1% | CN¥15.73 Million | CN¥15.73 Million | CN¥- | CN¥222.62 Million | ▼ -4.2 pp |
| 2017 | 11.2% | CN¥12.87 Million | CN¥12.87 Million | CN¥- | CN¥114.60 Million | — |